Abstract
In moderate and severe Chronic Obstructive Pulmonary Disease (COPD), the increased mechanical loads due to airflow limitation and the geometrical changes of the thorax due to lung hyperinflation alter the structure of the chest wall and the function of the respiratory muscles. In patients with severe hyperinflation and COPD the diaphragm retains the intrinsic properties to generate pressure and its capacity to generate tidal volume during breathing at rest is preserved. However, the increase of respiratory drive (motoneuronal discharge frequency to the diaphragm) and remodelling of the fibre types represent respectively functional and structural adaptations of this muscle to the disease. The abdominal expiratory muscles play an important role in the presence of COPD. Expiratory muscle activity has been observed in a significant portion of patients both at rest and during exercise. Even if the functional significance of expiratory muscle activity is still to be completely understood, there is increasing body of evidence that, in addition to other important factors like dynamic hyperinflation and the related dyspnoea or deconditioning of peripheral muscles, chest wall mechanics, in particular excessive expiratory pressures, can be a potent factor contributing to exercise limitation in COPD.
Keywords: Chest wall, COPD, diaphragm, abdominal muscles, resting breathing, exercise
Current Respiratory Medicine Reviews
Title: Chest Wall Mechanics in COPD
Volume: 4 Issue: 4
Author(s): Andrea Aliverti
Affiliation:
Keywords: Chest wall, COPD, diaphragm, abdominal muscles, resting breathing, exercise
Abstract: In moderate and severe Chronic Obstructive Pulmonary Disease (COPD), the increased mechanical loads due to airflow limitation and the geometrical changes of the thorax due to lung hyperinflation alter the structure of the chest wall and the function of the respiratory muscles. In patients with severe hyperinflation and COPD the diaphragm retains the intrinsic properties to generate pressure and its capacity to generate tidal volume during breathing at rest is preserved. However, the increase of respiratory drive (motoneuronal discharge frequency to the diaphragm) and remodelling of the fibre types represent respectively functional and structural adaptations of this muscle to the disease. The abdominal expiratory muscles play an important role in the presence of COPD. Expiratory muscle activity has been observed in a significant portion of patients both at rest and during exercise. Even if the functional significance of expiratory muscle activity is still to be completely understood, there is increasing body of evidence that, in addition to other important factors like dynamic hyperinflation and the related dyspnoea or deconditioning of peripheral muscles, chest wall mechanics, in particular excessive expiratory pressures, can be a potent factor contributing to exercise limitation in COPD.
Export Options
About this article
Cite this article as:
Aliverti Andrea, Chest Wall Mechanics in COPD, Current Respiratory Medicine Reviews 2008; 4 (4) . https://dx.doi.org/10.2174/157339808786263815
DOI https://dx.doi.org/10.2174/157339808786263815 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of Nitric Oxide in Motor Control: Implications for Parkinsons Disease Pathophysiology and Treatment
Current Pharmaceutical Design Glucose Metabolism and Insulin Resistance in Sepsis
Current Pharmaceutical Design Left Atrial Appendage Closure -The WATCHMAN Device
Current Cardiology Reviews Medicinal Agents and Metabolic Syndrome
Current Medicinal Chemistry Computer Simulation of the Effects of Contrast Protocols on Aortic Signal Intensity on Magnetic Resonance Angiograms
Current Medical Imaging Cell Cycle Arrest as a Therapeutic Target of Acute Kidney Injury
Current Protein & Peptide Science Neurological Disorders of Purine and Pyrimidine Metabolism
Current Topics in Medicinal Chemistry Cardiac Dys-Synchronization and Arrhythmia in Hyperhomocysteinemia
Current Neurovascular Research Brain Excitatory/Inhibitory Circuits Cross-Talking with Chromogranin A During Hypertensive and Hibernating States
Current Medicinal Chemistry Cellular and Molecular Mechanisms of Low Cardiac Output Syndrome after Pediatric Cardiac Surgery
Current Vascular Pharmacology Medication-Induced Nephrotoxicity in Older Patients
Current Drug Metabolism Force Denaturation of Proteins - an Unfolding Story
Current Nanoscience Bv8-Prokineticins and their Receptors: Modulators of Pain
Current Pharmaceutical Biotechnology Is the Modulation of Autophagy the Future in the Treatment of Neurodegenerative Diseases?
Current Topics in Medicinal Chemistry Metabolic Acidosis in Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Enhancement of Dissolution Rate of Furosemide Using a Solid Dispersion with D-Glucosamine HCl
Current Pharmaceutical Analysis Gut Permeability and Microbiota in Parkinson’s Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways
Current Pharmaceutical Design Challenges and Opportunities for Bacterial Vaccine Development in the 21<sup>st</sup> Century
Current Pharmaceutical Biotechnology Compounds that Combine Aldose Reductase Inhibitory Activity and Ability to Prevent the Glycation (Glucation and/or Fructation) of Proteins as Putative Pharmacotherapeutic Agents
Drug Design Reviews - Online (Discontinued) Mechanisms of Protective Effects of SGLT2 Inhibitors in Cardiovascular Disease and Renal Dysfunction
Current Topics in Medicinal Chemistry